Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Valneva Se ADR (VALN)

Valneva Se ADR (VALN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 928,355
  • Shares Outstanding, K 69,177
  • Annual Sales, $ 411,820 K
  • Annual Income, $ -86,870 K
  • 60-Month Beta 3.21
  • Price/Sales 2.27
  • Price/Cash Flow N/A
  • Price/Book 5.62
Trade VALN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.22
  • Number of Estimates 2
  • High Estimate 0.23
  • Low Estimate 0.20
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.23 +4.26%
on 11/28/22
14.99 -14.94%
on 11/15/22
-0.30 (-2.33%)
since 10/28/22
3-Month
9.77 +30.50%
on 09/29/22
19.92 -35.99%
on 08/30/22
-5.54 (-30.28%)
since 08/29/22
52-Week
9.77 +30.50%
on 09/29/22
67.84 -81.21%
on 11/29/21
-46.85 (-78.61%)
since 11/26/21

Most Recent Stories

More News
Wall Street Analysts See a 65% Upside in Valneva SE Sponsored ADR (VALN): Can the Stock Really Move This High?

The mean of analysts' price targets for Valneva SE Sponsored ADR (VALN) points to a 65.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

VALN : 12.75 (-4.99%)
All You Need to Know About Valneva SE Sponsored ADR (VALN) Rating Upgrade to Buy

Valneva SE Sponsored ADR (VALN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VALN : 12.75 (-4.99%)
Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why

Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.

AZN : 66.08 (-0.20%)
PFE : 49.49 (-0.16%)
MORF : 26.59 (-0.08%)
VALN : 12.75 (-4.99%)
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of PreHevbri®...

VALN : 12.75 (-4.99%)
VBIV : 0.5579 (-6.89%)
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524),...

VALN : 12.75 (-4.99%)
PFE : 49.49 (-0.16%)
Why Dynavax Crushed the Market on Thursday

Its partner's coronavirus vaccine comes one important step closer to approval in Europe.

DVAX : 11.88 (-0.42%)
VALN : 12.75 (-4.99%)
Valneva SE Sponsored ADR (VALN) Stock Jumps 93.1%: Will It Continue to Soar?

Valneva SE Sponsored ADR (VALN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...

VALN : 12.75 (-4.99%)
TGTX : 8.13 (+1.88%)
Pfizer (PFE) to Buy 8.1% Stake in Lyme Disease Vaccine Partner

Pfizer (PFE) is set to acquire 8.1% stake in Valneva's stock. Valneva will use the cash from this investment to support its phase III study for VLA15.

PFE : 49.49 (-0.16%)
ALKS : 24.02 (+0.21%)
SESN : 0.5600 (+4.67%)
VALN : 12.75 (-4.99%)
The Shopify Split Is Just Days Away, but This Tiny Nasdaq Stock Is Soaring Right Now

Markets looked poised for a rebound on Tuesday.

COMP : 2.69 (-0.37%)
$DOWI : 33,852.53 (+0.01%)
$SPX : 3,957.63 (-0.16%)
$NASX : 10,983.78 (-0.59%)
SHOP : 37.15 (-2.31%)
VALN : 12.75 (-4.99%)
PFE : 49.49 (-0.16%)
Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Equity Subscription Agreement and have updated...

VALN : 12.75 (-4.99%)
PFE : 49.49 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.

See More

Key Turning Points

3rd Resistance Point 13.12
2nd Resistance Point 12.94
1st Resistance Point 12.84
Last Price 12.75
1st Support Level 12.56
2nd Support Level 12.38
3rd Support Level 12.28

See More

52-Week High 67.84
Fibonacci 61.8% 45.66
Fibonacci 50% 38.81
Fibonacci 38.2% 31.95
Last Price 12.75
52-Week Low 9.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar